Literature DB >> 12635174

Modifiers of risk of hereditary breast and ovarian cancer.

Steven A Narod1.   

Abstract

Hereditary breast and ovarian cancer is among the most commonly encountered adult genetic disease, and it is increasingly important that geneticists, oncologists, surgeons and gynaecologists are aware of the issues regarding risk assessment, prevention and management of women with inherited susceptibility to cancer. Genetic risk can be modified by external factors, but what are these factors, and how might our knowledge of them help us to better define the risks for individual women and to develop strategies for cancer prevention?

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12635174     DOI： 10.1038/nrc726

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


  55 in total

1.  Mutations in Fanconi anemia genes and the risk of esophageal cancer.

Authors:  Mohammad R Akbari; Reza Malekzadeh; Pierre Lepage; David Roquis; Ali R Sadjadi; Karim Aghcheli; Abbas Yazdanbod; Ramin Shakeri; Jafar Bashiri; Masoud Sotoudeh; Akram Pourshams; Parviz Ghadirian; Steven A Narod
Journal:  Hum Genet       Date:  2011-01-30       Impact factor: 4.132

2.  Genetic counselors: translating genomic science into clinical practice.

Authors:  Robin L Bennett; Heather L Hampel; Jessica B Mandell; Joan H Marks
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

3.  Targeting progesterone signaling prevents metastatic ovarian cancer.

Authors:  Olga Kim; Eun Young Park; Sun Young Kwon; Sojin Shin; Robert E Emerson; Yong-Hyun Shin; Francesco J DeMayo; John P Lydon; Donna M Coffey; Shannon M Hawkins; Lawrence A Quilliam; Dong-Joo Cheon; Facundo M Fernández; Kenneth P Nephew; Adam R Karpf; Martin Widschwendter; Anil K Sood; Robert C Bast; Andrew K Godwin; Kathy D Miller; Chi-Heum Cho; Jaeyeon Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-01       Impact factor: 11.205

Review 4.  Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Authors:  David J Hughes
Journal:  Fam Cancer       Date:  2008-02-19       Impact factor: 2.375

5.  Genetic variants of EGFR (142285G>A) and ESR1 (2014G>A) gene polymorphisms and risk of breast cancer.

Authors:  Ranbir Chander Sobti; Marjan Askari; Mohsen Nikbakht; Neha Singh; Suresh C Sharma; Abayneh Munshea Abitew
Journal:  Mol Cell Biochem       Date:  2012-07-19       Impact factor: 3.396

Review 6.  Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.

Authors:  Tara M Friebel; Susan M Domchek; Timothy R Rebbeck
Journal:  J Natl Cancer Inst       Date:  2014-06       Impact factor: 13.506

7.  Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population.

Authors:  Sharon Simchoni; Eitan Friedman; Bella Kaufman; Ruth Gershoni-Baruch; Avi Orr-Urtreger; Inbal Kedar-Barnes; Ronit Shiri-Sverdlov; Efrat Dagan; Sigal Tsabari; Mordechai Shohat; Raphael Catane; Mary-Claire King; Amnon Lahad; Ephrat Levy-Lahad
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-28       Impact factor: 11.205

Review 8.  From monogenic to polygenic obesity: recent advances.

Authors:  Anke Hinney; Carla I G Vogel; Johannes Hebebrand
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-02-03       Impact factor: 4.785

9.  The prevention of hereditary breast and ovarian cancer: a personal view.

Authors:  Steven Narod
Journal:  Hered Cancer Clin Pract       Date:  2004-02-15       Impact factor: 2.857

10.  Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations.

Authors:  David Barzan; Marlon R Veldwijk; Carsten Herskind; Yang Li; Bo Zhang; Elena Sperk; Wei-Dong Du; Xue-Jun Zhang; Frederik Wenz
Journal:  Eur J Hum Genet       Date:  2013-03-13       Impact factor: 4.246
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.